Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin K1 to slow vascular calcification in hemodialysis patients
2010-021264-14Phase 2Terminated
- Sponsor
- RWTH Aachen University
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of phytomenadione in end-stage kidney disease (ESKD) and arterial calcification (2 arms), sponsored by RWTH Aachen University. Primary endpoint: Aortic calcification (volume score). Started Sep 2012; status: terminated.
02
Drugs
phytomenadione
03
Conditions
end-stage kidney disease (ESKD)arterial calcification
Beyond the preview
Go deeper on 2010-021264-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021264-14.